Computer-aided drugs are drugs that are produced based on computer chemistry, through computer simulations, calculations, and budgeting of the relationship between drugs and receptor biomacromolecules, and design and optimization of lead compounds. Computer-aided drug design is actually the optimization and design of lead compounds by simulating and calculating this interaction between receptors and ligands.

Market Analysis and Insights: Global Computer-Aided Drug Market
The global Computer-Aided Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Computer-Aided Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Computer-Aided Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Computer-Aided Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Computer-Aided Drug market.

Global Computer-Aided Drug Scope and Market Size
Computer-Aided Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Computer-Aided Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Structure Based Drug
Ligand Based Drug

Segment by Application
Oncological Disorders
Neurological Disorders
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Market Positioning Of Vendors
Aaranya Biosciences Pvt. Ltd.
Albany Molecular Research Inc.
Charles River Laboratories International Inc.
Chembio Discovery Inc.
Chemical Computing Group ULC
Compchem Solutions Ltd.
International Business Machines Corp.
Kang Yusheng Information Technology Co. Ltd.
Openeye Scientific Software Inc.
Pharmaron Beijing Co. Ltd.